Details for Patent: 5,485,827
✉ Email this page to a colleague
Summary for Patent: 5,485,827
| Title: | Methods and devices for treating plumonary vasoconstriction and asthma |
| Abstract: | A method for treating or preventing bronchoconstriction or reversible pulmonary vasoconstriction in a mammal, which method includes causing the mammal to inhale a therapeutically-effective concentration of gaseous nitric oxide or a therapeutically-effective amount of a nitric oxide-releasing compound, and an inhaler device containing nitric oxide gas and/or a nitric oxide-releasing compound. |
| Inventor(s): | Zapol; Warren M. (Concord, MA), Frostell; Claes (Danderyd, SE) |
| Assignee: | The General Hospital Corporation (Boston, MA) |
| Application Number: | 08/384,792 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Device; Compound; |
Drugs Protected by US Patent 5,485,827
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,485,827
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 0560928 | ⤷ Sign Up | CA 2002 00002 | Denmark | ⤷ Sign Up |
| European Patent Office | 0560928 | ⤷ Sign Up | SPC/GB02/009 | United Kingdom | ⤷ Sign Up |
| European Patent Office | 0560928 | ⤷ Sign Up | 2002C/003 | Belgium | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
